News
Govtto decide on hydroxychloroquinefor COVID-19 case management
Ghana’s COVID-19 case management team is deliberating on whether to continue or stop using hydroxychloroquine as one of the drugs for the management of the disease in the country.
This comes on the heels of a decision by the World Health Organisation (WHO) to halt the testing of the malaria drug as a possible treatment for coronavirus over safety fears discovered in some recent studies.
The Director–General of the Ghana Health Service (GHS) DrPatrick Aboagye who disclosed this at yesterday’s COVID-19 briefing in Accra said the decision would be announced in due course.
“As I speak now, of course, we will wait for the formal communication but the case management team is meeting to take a decision on what to do. When they do we will adequately communicate to you”, he said.
He, however, explained that the drug in question was currentlyadministered to only persons under criticalconditions, adding that those being managed at their respective houses do not take hydroxychloroquine.
“We only use it [hydroxychloroquine] for critical cases. We do not use it for routine cases. Those who are being managed at home do not take hydroxychloroquine”, he explained.
Hydroxychloroquine was an approved drug for the treatment of malaria as well as conditions like lupus or arthritis. In the absence of a cure for COVID-19 it has been helping in case management. The ongoing testing was to confirm its efficacy.
However, WHO director-general TedrosAdhanomGhebreyesuson Monday said the drug would be dropped temporarily from its global study into experimental coronavirus treatments after safety concerns.
The concerns were discovered by a paper published last week in the Lancet that showed people taking the drug were at higher risk of death and heart problems than those who were not.
“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the solidarity trial while the safety data is reviewed by the data safety monitoring board,” MrGhebreyesussaid.
He said the concern related only to the use of hydroxychloroquine and chloroquine for COVID-19, adding that the drugs were acknowledged treatments for people with malaria and auto-immune diseases.
Other treatments in the WHO’s solidarity trial, including the experimental drug remdesivir and an HIV combination therapy, he said were still being pursued by scientists.
BY JONATHAN DONKOR
The Second Deputy Minority Whip, Jerry Ahmed Shaib, has defended the conduct of the Minority in Parliament during Tuesday’s chaotic sitting, insisting their actions were to protect what they believe is a violation of parliamentary procedure.
Explaining the incident, he said the Minority was reacting to developments surrounding a letter which allegedly directed that a seat belonging to the MP for Kpandai be declared vacant despite an earlier ruling by the Speaker.
He argued that the Speaker’s ruling should stand unless overturned by a competent court, and described the sudden reversal as shocking and against parliamentary precedent.
Mr Ahmed said the Minority only attempted to make a statement to register their displeasure, but tensions rose when the Majority Leader insisted on responding instead of commenting, which he said was against the rules.
He also denied claims that Minority MPs crossed the aisle, stressing that they remained within their side and only sought the Speaker’s attention.
He further complained that during proceedings, the Mace—the symbol of authority in the House—was not present and Minority microphones were disconnected, making the process one-sided.
He said the caucus intends to continue pushing to ensure that the MP for Kpandai retains his seat, adding that their next steps will be strategic.
By: Jacob Aggrey
President John Mahama has stated that it is too early for anyone to call for the scrapping of the Office of the Special Prosecutor (OSP) despite recent controversies surrounding the institution.
He argued that the office remains an important part of Ghana’s fight against corruption.
He explained that government is strengthening anti-corruption bodies such as the Economic and Organised Crime Office and the OSP, noting that the OSP is the only agency with the power to independently prosecute cases without going through the Attorney General.
President Mahama said many people distrust the Attorney General’s office because it is headed by a government minister, and some fear it may be slow to prosecute its own.
He believes an independent body like the OSP offers stronger accountability, regardless of who is involved.
He admitted that citizens want to see more prosecutions and visible results, but urged the public to give the OSP time.
He encouraged the office to speed up its investigations to show that it remains relevant in the fight against corruption.
By: Jacob Aggrey
